Urology Vol. III
Four topics, 41 cases — choose one below to browse its cases.
Intravesical therapy sequencing during a BCG shortage, bladder preservation versus cystectomy in BCG-unresponsive disease, GnRH antagonist versus agonist cardiovascular risk, bone-protective agent selection, biochemical recurrence timing, 5-alpha-reductase inhibitor use during active surveillance, upper tract urothelial carcinoma management, extended VTE prophylaxis after cystectomy, and fertility preservation in testicular cancer
Vesicoureteral reflux prophylaxis, antenatal hydronephrosis management, pediatric neurogenic detrusor overactivity drug selection, onabotulinumtoxinA for oral-refractory disease, desmopressin/alarm therapy and third-line imipramine for enuresis, hormonal therapy before orchiopexy, preoperative androgen stimulation before hypospadias repair, asymptomatic bacteriuria on catheterization, and adjunctive corticosteroids in pyelonephritis
Recurrent UTI prophylaxis after exhausting first-line options, resistant-organism antibiotic selection, antibiotic duration around an infected obstructed kidney, asymptomatic bacteriuria before procedures, catheter-associated bacteriuria versus true infection, penile prosthesis salvage timing, asymptomatic candiduria, infant febrile UTI, dual-risk epididymitis treatment, and off-label oral fosfomycin for multidrug-resistant UTI
Ureteral stent timing after a tense anastomosis, asymptomatic bacteriuria beyond the early post-transplant window, recurrent UTI from ureteral reimplant reflux, immunosuppression selection in a neurogenic-bladder recipient, tacrolimus-sildenafil interaction asymmetry, mycophenolate washout timing before conception, sirolimus conversion after recurrent skin cancer, and NSAID/thromboprophylaxis decisions in a living kidney donor